e-learning
resources
Virtual 2020
Pre-Congress Content
Molecular alterations and immunology in lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - The role of the transcription factor PU.1 in lung cancer
K. Hohenberger (Erlangen, Germany), D. Trufa (Erlangen, Germany), C. Gebbert (Erlangen, Germany), R. Rieker (Erlangen, Germany), H. Sirbu (Erlangen, Germany), S. Finotto (Erlangen, Germany)
Source:
Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Session:
Molecular alterations and immunology in lung cancer
Session type:
E-poster session
Number:
1642
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Hohenberger (Erlangen, Germany), D. Trufa (Erlangen, Germany), C. Gebbert (Erlangen, Germany), R. Rieker (Erlangen, Germany), H. Sirbu (Erlangen, Germany), S. Finotto (Erlangen, Germany). Late Breaking Abstract - The role of the transcription factor PU.1 in lung cancer. 1642
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Definition and history of sarcoidosis
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Related content which might interest you:
Late Breaking Abstract - Induction of the transcriptional repressor B lymphocytes-induced maturation protein-1 (Blimp-1) in lung cancer
Source: Virtual Congress 2020 – Biological aspects of lung cancer
Year: 2020
Late Breaking Abstract - ERBB3 involved in growth factor pathway crosstalk during neonatal lung development in a 3D ex vivo model
Source: Virtual Congress 2021 – Paediatric lung disease: novel mechanisms, methods and translational studies
Year: 2021
Downregulation of Thyroid transcription factor 1 in lung adenocarcinoma: the prognostic impact
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018
Transcription factor FOXF1 induces cancer-associated fibroblast-like phenotype to promote lung cancer progression
Source: Annual Congress 2009 - Pathogenesis of lung cancer
Year: 2009
The role of FoxO transcription factors in normal and aberrant late lung development
Source: International Congress 2017 – Molecular pathways in lung development
Year: 2017
Expression of C/EBP transcription factors in mouse lung development
Source: Eur Respir J 2002; 20: Suppl. 38, 572s
Year: 2002
Late Breaking Abstract - Role of interleukin-10 in normal and aberrant late lung development
Source: International Congress 2017 – Postnatal lung growth and development
Year: 2017
Late Breaking Abstract: Galectin-3 a key regulator in the development of lung fibrosis
Source: Annual Congress 2010 - Stem cells and growth factors in lung injury
Year: 2010
Late Breaking Abstract - Mapping fibroblast activity in IPF– the instructive lung ECM
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020
Late Breaking Abstract: The role of galectin-3 on macrophages in CNT-induced mouse lung inflammation
Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics
Year: 2010
Late Breaking Abstract - Pigment epithelium-derived factor regulates cigarette-induced abnormal apoptosis of alveolar type II cells
Source: International Congress 2019 – Advances in COPD pharmacology
Year: 2019
Transforming Growth factor beta-1 and Smad signaling has the potential to drive EMT-related changes in smokers and COPD
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
Late Breaking Abstract - Anaplastic Lymphoma Kinase inhibition as an effective treatment strategy against the enhanced lung carcinogenesis and cancer angiogenesis related to decreased PTPRZ1 expression
Source: Virtual Congress 2020 – Biological aspects of lung cancer
Year: 2020
Late Breaking Abstract - Decreased thrombospondin-1 and bone morphogenetic protein-4 serum levels in non-small-cell lung cancer and the relationship of these proteins with the stage of the disease.
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017
Late Breaking Abstract - Roles for transglutaminases in normal and aberrant lung development associated with BPD.
Source: International Congress 2017 – Late-breaking findings in pulmonary diseases
Year: 2017
Asthma and diabetes: Possible markers of their co-existence. The possible role of transcription factors GATA-3 and T-bet and negative regulator of transcription SOCS1 in the worsening of asthma
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015
Targeted silencing of master transcription factor SPDEF to reduce mucus production in airway diseases by epigenetic editing
Source: International Congress 2015 – Advances in the future treatment of COPD
Year: 2015
Rac-specific nucleotide exchange factor Asef mediates lung endothelial barrier protection by hepatocyte growth factor
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
Mesenchyme associated transcription factor PRRX1: A key regulator of IPF fibroblast
Source: International Congress 2016 – Repair pathways: from lung development to ageing of the lung
Year: 2016
Cigarette smoke inhibits lung fibroblast proliferation by translational mechanisms
Source: Eur Respir J 2012; 39: 705-711
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept